CardioNerds
CardioNerds
Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!
Advertisement
CardioNerdsCardioNerds | December 18, 2024
The CardioNerds and colleagues review the differential diagnosis for peripartum cardiomyopathy.
Listen Now
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles.
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM.
CardioNerdsCardioNerds | December 2, 2024
The CardioNerds discuss a case involving a patient who presented with stress cardiomyopathy leading to cardiogenic shock.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
A study highlights the significant HCRU and costs associated with ATTR-CM.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
CardioNerdsCardioNerds | December 3, 2024
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Amit Goyal, MDTCT 2024 | December 4, 2024
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
Amit Goyal, MDTCT 2024 | December 4, 2024
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
Amit Goyal, MDTCT 2024 | December 4, 2024
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
Rob DillardCardioNerds | November 4, 2024
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
Amit Goyal, MDCardioNerds | September 26, 2024
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
Amit Goyal, MDCardioNerds | September 25, 2024
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
CardioNerdsCardioNerds | September 26, 2024
The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy.
Amit Goyal, MDInterventional Cardiology | September 11, 2024
The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI.
Amit Goyal, MDAtrial Fibrillation | September 10, 2024
The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD.
Amit Goyal, MDESC Congress 2024 | September 4, 2024
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
Amit Goyal, MDESC Congress 2024 | September 3, 2024
The NOTION 3 trial contributes important data to the ongoing debate about the role of PCI before TAVI in patients with CAD.
Amit Goyal, MDCardioNerds | August 14, 2024
Dr. Amit Goyal details the bRIGHT study, which offers a valuable glimpse into the performance of the Abbott TriClip device.
CardioNerdsCardioNerds | October 17, 2024
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
Advertisement
Advertisement
Advertisement
Latest News

December 20, 2024